Lung cancer (Amsterdam, Netherlands)
International Standard Serial Number (ISSN)
publication venue for
Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer.
Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk.
Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer.